Holen Sie sich die Stockscreener-App
90.80
0.36%
0.33
Handel nachbörslich:
90.80
Schlusskurs vom Vortag:
$90.47
Offen:
$90.62
24-Stunden-Volumen:
1.83M
Relative Volume:
1.85
Marktkapitalisierung:
$12.36B
Einnahmen:
$2.48B
Nettoeinkommen (Verlust:
$91.51M
KGV:
135.52
EPS:
0.67
Netto-Cashflow:
$293.77M
1W Leistung:
+4.28%
1M Leistung:
+8.85%
6M Leistung:
+24.71%
1J Leistung:
+65.33%
1-Tages-Spanne:
$89.34
$91.04
1-Wochen-Bereich:
$86.28
$91.44
52-Wochen-Spanne:
$49.33
$91.44
Globus Medical Inc Stock (GMED) Company Profile
Firmenname
Globus Medical Inc
Sektor
Branche
Telefon
610-930-1800
Adresse
2560 GENERAL ARMISTEAD AVENUE, AUDUBON, PA
Vergleichen Sie GMED mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GMED
Globus Medical Inc
|
90.80 | 12.36B | 2.48B | 91.51M | 293.77M | 0.67 |
|
ABT
Abbott Laboratories
|
113.48 | 196.83B | 41.22B | 5.77B | 6.49B | 3.29 |
|
SYK
Stryker Corp
|
383.42 | 146.17B | 21.97B | 3.59B | 3.21B | 9.33 |
|
BSX
Boston Scientific Corp
|
98.66 | 145.41B | 15.91B | 1.79B | 1.89B | 1.21 |
|
MDT
Medtronic Plc
|
88.08 | 112.94B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
69.78 | 41.16B | 6.60B | 4.16B | 490.10M | 6.93 |
Globus Medical Inc Stock (GMED) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-01-10 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2024-12-02 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2024-08-07 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-05-20 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2024-03-18 | Hochstufung | BTIG Research | Neutral → Buy |
| 2023-10-20 | Eingeleitet | ROTH MKM | Buy |
| 2023-09-19 | Hochstufung | Stifel | Hold → Buy |
| 2023-03-30 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2023-02-13 | Herabstufung | BofA Securities | Buy → Underperform |
| 2023-02-10 | Herabstufung | BTIG Research | Buy → Neutral |
| 2023-02-10 | Herabstufung | Loop Capital | Buy → Hold |
| 2023-02-10 | Herabstufung | Needham | Buy → Hold |
| 2023-02-10 | Herabstufung | Truist | Buy → Hold |
| 2023-02-10 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-10-18 | Eingeleitet | Barclays | Overweight |
| 2022-10-12 | Eingeleitet | Jefferies | Buy |
| 2022-04-13 | Fortgesetzt | Truist | Buy |
| 2022-03-28 | Eingeleitet | Wells Fargo | Overweight |
| 2022-01-04 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2021-12-13 | Hochstufung | BofA Securities | Underperform → Buy |
| 2021-12-10 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2021-10-29 | Eingeleitet | Loop Capital | Buy |
| 2021-02-18 | Fortgesetzt | Needham | Buy |
| 2020-12-08 | Eingeleitet | Citigroup | Buy |
| 2020-10-20 | Eingeleitet | Stifel | Hold |
| 2020-08-06 | Bestätigt | Needham | Buy |
| 2020-08-06 | Hochstufung | Northland Capital | Market Perform → Outperform |
| 2020-07-21 | Eingeleitet | Northland Capital | Market Perform |
| 2020-07-06 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2020-05-08 | Bestätigt | Needham | Buy |
| 2020-03-18 | Hochstufung | BTIG Research | Neutral → Buy |
| 2020-01-08 | Eingeleitet | SunTrust | Buy |
| 2019-12-12 | Hochstufung | Wells Fargo | Market Perform → Outperform |
| 2019-08-02 | Bestätigt | Needham | Buy |
| 2019-05-24 | Herabstufung | Wells Fargo | Outperform → Market Perform |
| 2019-05-03 | Bestätigt | Needham | Buy |
| 2019-02-28 | Hochstufung | UBS | Neutral → Buy |
| 2019-01-02 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2018-08-02 | Bestätigt | Needham | Buy |
| 2018-06-27 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2018-06-01 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2018-05-03 | Bestätigt | Needham | Buy |
| 2018-04-04 | Hochstufung | Needham | Hold → Buy |
Alle ansehen
Globus Medical Inc Aktie (GMED) Neueste Nachrichten
Will Globus Medical (GMED) Beat Estimates Again in Its Next Earnings Report? - Yahoo Finance
Here's Why Globus Medical (GMED) is a Strong Growth Stock - Yahoo Finance
Globus Medical (STU:GM0N) Earnings Yield % : 0.70% (As of Jan. 19, 2025) - GuruFocus.com
Oak Thistle LLC Acquires New Shares in Globus Medical, Inc. (NYSE:GMED) - MarketBeat
Globus Medical (NYSE:GMED) Sets New 1-Year HighWhat's Next? - MarketBeat
Globus Medical, Inc. (NYSE:GMED) Shares Sold by Covea Finance - MarketBeat
Kathmere Capital Management LLC Buys New Position in Globus Medical, Inc. (NYSE:GMED) - MarketBeat
Globus Medical Reports Robust Q3 2024 Financial Performance and Raises Annual Outlook - MSN
Globus medical COO Keith Pfeil sells $1.25 million in stock By Investing.com - Investing.com Canada
Globus medical COO Keith Pfeil sells $1.25 million in stock - Investing.com India
Keith W. Pfeil Sells 14,167 Shares of Globus Medical, Inc. (NYSE:GMED) Stock - MarketBeat
FY2024 EPS Estimates for Globus Medical Increased by Analyst - MarketBeat
Brokerages Set Globus Medical, Inc. (NYSE:GMED) Price Target at $96.91 - MarketBeat
Globus Medical (STU:GM0N) Capex-to-Operating-Cash-Flow : 0.21 (As of Sep. 2024) - GuruFocus.com
Globus Medical Reports Record Sales Growth for 2024 - MSN
Globus Medical anticipates Q4 sales of $657 million - MSN
GMED Stock Rides on NuVasive Synergy Benefits Amid Macro Issues - MSN
Canaccord Genuity Group Forecasts Strong Price Appreciation for Globus Medical (NYSE:GMED) Stock - MarketBeat
Globus Medical stock soars to all-time high of $88.67 - Investing.com
Globus Medical upgraded to Neutral from Underperform at BofA - Yahoo Finance
Globus Medical (MEX:GMED) Net Income : MXN1,740 Mil (TTM As of Sep. 2024) - GuruFocus.com
Globus Medical (MEX:GMED) EPS without NRI : MXN44.05 (TTM As of Sep. 2024) - GuruFocus.com
Globus Medical, Inc.'s (NYSE:GMED) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock? - Simply Wall St
B of A Securities Upgrades Globus Medical (GMED) - MSN
Truist maintains hold on Globus Medical, keeps $90 target By Investing.com - Investing.com Canada
Globus Medical upgraded to neutral by BoA on Q4 performance - MSN
Globus Medical stock upgraded to Neutral after better-than-expected NuVasive integration - Investing.com Canada
Globus Medical (NYSE:GMED) Stock Rating Upgraded by Bank of America - MarketBeat
Globus Medical (NYSE:GMED) Receives Hold Rating from Needham & Company LLC - MarketBeat
Globus Medical, Inc. (NYSE:GMED) Shares Sold by Diversified Trust Co - MarketBeat
Globus Medical reports increased sales, optimistic 2025 outlook By Investing.com - Investing.com Australia
Globus Medical, Inc. Provides Sales Results for the Fourth Quarter and Full Year Ended December 31, 2024 and Provides Earnings Guidance for the Full Year Fiscal 2025 - Marketscreener.com
Globus Medical (NYSE:GMED) Updates FY 2025 Earnings Guidance - MarketBeat
Globus Medical reports increased sales, optimistic 2025 outlook - Investing.com
Globus Medical Reports Preliminary Record Fourth Quarter and Full Year Sales Results - The Manila Times
Globus Medical Reports Strong 60.6% Sales Growth, Sets Ambitious $2.69B Revenue Target for 2025 - StockTitan
Globus Medical (NYSE:GMED) Trading Up 3%Here's What Happened - MarketBeat
The Law Offices of Frank R. Cruz Continues Its Investigation of Globus Medical, Inc. (GMED) on Behalf of Investors - Business Wire
Confocal Microscopy Market Expected to Expand at a Steady from - openPR
Globus Medical Stock Revs Up For Next Move After 70% Run - MSN
Price Over Earnings Overview: Globus Medical - Benzinga
Why Globus Medical (GMED) is a Top Growth Stock for the Long-Term - MSN
Globus Medical, Inc. (NYSE:GMED) Shares Sold by JPMorgan Chase & Co. - MarketBeat
Globus Medical gets FDA approval for two knee replacement products - MSN
Principal Financial Group Inc. Decreases Stake in Globus Medical, Inc. (NYSE:GMED) - MarketBeat
Franklin Resources Inc. Takes Position in Globus Medical, Inc. (NYSE:GMED) - MarketBeat
Reasons to Add GMED Stock to Your Portfolio Right Now - MSN
Globus Medical: Strong Q3 Sales and Product Intros - https://ryortho.com/
This Globus Medical Insider Reduced Their Stake By 100% - Simply Wall St
Roth Capital Raises Earnings Estimates for Globus Medical - MarketBeat
Finanzdaten der Globus Medical Inc-Aktie (GMED)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.25%
0.57%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):